These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24466036)

  • 21. Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways.
    Zhang XJ; Jia SS
    Biomed Pharmacother; 2016 Oct; 83():1164-1174. PubMed ID: 27551764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
    Xu J; Shi J; Tang W; Jiang P; Guo M; Zhang B; Ma G
    J Cell Biochem; 2020 Oct; 121(10):4142-4153. PubMed ID: 32048761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bornyl
    Yang TY; Wu ML; Chang CI; Liu CI; Cheng TC; Wu YJ
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SSRP1 Worsens Malignant Melanoma Progression by Activating MAPKs Pathway.
    Yu Y; Gao Y; Yu Y
    Ann Clin Lab Sci; 2021 Nov; 51(6):783-789. PubMed ID: 34921031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models.
    Chamcheu JC; Esnault S; Adhami VM; Noll AL; Banang-Mbeumi S; Roy T; Singh SS; Huang S; Kousoulas KG; Mukhtar H
    Cells; 2019 Sep; 8(9):. PubMed ID: 31540162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
    Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
    Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Grape seed proanthocyanidins inhibit migration potential of pancreatic cancer cells by promoting mesenchymal-to-epithelial transition and targeting NF-κB.
    Prasad R; Katiyar SK
    Cancer Lett; 2013 Jun; 334(1):118-26. PubMed ID: 22902508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
    Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
    Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway.
    Luo W; Liu X; Sun W; Lu JJ; Wang Y; Chen X
    Phytother Res; 2018 Oct; 32(10):2009-2020. PubMed ID: 29952428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of ER stress and activation of apoptotic pathways in fisetin induced cytotoxicity in human melanoma.
    Syed DN; Lall RK; Chamcheu JC; Haidar O; Mukhtar H
    Arch Biochem Biophys; 2014 Dec; 563():108-117. PubMed ID: 25016296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Li Y; Zhu X; Zeng Y; Wang J; Zhang X; Ding YQ; Liang L
    Mol Cancer Res; 2010 Dec; 8(12):1579-90. PubMed ID: 21071512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oleanolic acid suppresses migration and invasion of malignant glioma cells by inactivating MAPK/ERK signaling pathway.
    Guo G; Yao W; Zhang Q; Bo Y
    PLoS One; 2013; 8(8):e72079. PubMed ID: 23991044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the ERK signaling pathway in fisetin reduces invasion and migration in the human lung cancer cell line A549.
    Liao YC; Shih YW; Chao CH; Lee XY; Chiang TA
    J Agric Food Chem; 2009 Oct; 57(19):8933-41. PubMed ID: 19725538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells.
    Wan XB; Long ZJ; Yan M; Xu J; Xia LP; Liu L; Zhao Y; Huang XF; Wang XR; Zhu XF; Hong MH; Liu Q
    Carcinogenesis; 2008 Oct; 29(10):1930-7. PubMed ID: 18667445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F; Liu T; Jin H; Wang W
    Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
    Luo W; Liu Q; Jiang N; Li M; Shi L
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways.
    Suh Y; Afaq F; Johnson JJ; Mukhtar H
    Carcinogenesis; 2009 Feb; 30(2):300-7. PubMed ID: 19037088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fisetin inhibits the generation of inflammatory mediators in interleukin-1β-induced human lung epithelial cells by suppressing the NF-κB and ERK1/2 pathways.
    Peng HL; Huang WC; Cheng SC; Liou CJ
    Int Immunopharmacol; 2018 Jul; 60():202-210. PubMed ID: 29758489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
    Sung B; Pandey MK; Aggarwal BB
    Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.